Basal cell carcinoma: Are early appointments justifiable?

British Journal of Dermatology

Volumn 142, Issue 3, 2000, Pages 446-448

  Gordon, P M ^b   Cox, N H ^a   Paterson, W D ^a   Lawrence, C M ^b  

^a CUMBERLAND INFIRMARY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Basal cell carcinoma; Hospital referral

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CONSULTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PATIENT REFERRAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DERMATOLOGY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; WAITING LISTS;

EID: 0034060425     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03354.x     Document Type: Article

References (13)

1. 1 Anonymous. The New NHS. Modern. Dependable (Government White Paper), Clause 1.13. The Stationary Office Ltd, 1997: 7.
2. 2 Williams HC. Dermatology Health Care Needs Assessment. Oxford: Radcliffe Medical Press, 1997; 23.
3. 3 Melia J, Cooper EJ, Frost T et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. I. Work-load and referral patterns. Br J Dermatol 1995; 132: 405-13.
4. 4 Mikhail GR, Nims LP, Kelly AP Jr et al. Metastatic basal cell carcinoma. Review, pathogenesis and report of 2 cases. Arch Dermatol 1977; 113: 1261-9.
5. 5 von Domarus H, Steven PJ. Metastatic basal cell carcinoma. Report of 5 cases and review of 170 cases in the literature. J Am Acad Dermatol 1984; 10: 1043-60.
6. 6 Blackford S, Roberts DL, Salek MS, Finlay AY. Basal cell carcinomas cause little handicap. Qual Life Res 1996; 5: 191-4.
7. 7 Doherty VR, MacKie RM. Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J 1986; 292: 987-9.
8. 8 Horlock NM, Wilson GD, Daley FM et al. Cellular proliferation characteristics of basal cell carcinoma: relationship to clinical subtype and histopathology. Eur J Surg Oncol 1997; 23: 247-52.
9. 9 Verhaegh ME, Sanders CJ, Arends JW, Neumann HA. Expression of the apoptosis-suppressing protein bcl-2 in non-melanoma skin cancer. Br J Dermatol 1995; 132: 740-4.
10. 10 Rosen K, Karabulut Thorup A, Hou-Jensen K, Krag Jacobsen G. BAX protein is not expressed by basal cell carcinomas. Br J Dermatol 1998; 139: 472-4.
11. 11 Weninger W, Rendl M, Pammer J et al. Differences in tumor microvessel density between squamous cell carcinomas and basal cell carcinomas may relate to their different biologic behaviour. J Cutan Pathol 1997; 24: 364-9.
12. 12 Kirkup ME, de Berker DA. Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery. Br J Dermatol 1999; 141: 876-9.
13. 13 Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast cancer symptoms. Lancet 1999; 353: 1132-5.